Company / Net Debt per Share
Terns Pharmaceuticals, Inc. Net Debt per Share History
FY2022-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Debt per Share
-$1.12
FY2023
5-year range
-$3.96 / -$1.12
FY2022-FY2023
Trend
+71.7%
vs FY2022
Sector context
#61 of 83
Health Care
What the data says
At $-1.12, Terns Pharmaceuticals, Inc.'s net debt per share ranks #23 of 83 in the Health Care sector.
Based on SEC 10-K filings.
-1.12 in FY2023.
Health Care sector context is included.
Net Debt per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#23 of 83 in Health CareTop 27% of 83This company -$1.12 Sector average $13.18
▼
-108.5% below sector average
Key checks
Key Insights
- In FY2023, net debt per share increased 71.7% year-over-year.
- Ranks #61 out of 83 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 7.86 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | - | - |
| FY2023 | -$1.12 | +71.7% |
| FY2022 | -$3.96 | - |
| FY2021 | - | - |
| FY2020 | - | - |
As of FY2023 · SEC 10-K · Updated Feb 28, 2026